Minderoo Children’s Comprehensive Cancer Centre is Australia’s first purpose-built children’s comprehensive cancer centre, co-locating world-leading paediatric clinical care and research to enable a fully integrated approach to the way children with cancer are treated.
Opening in Sydney in 2025, the centre will comprise purpose-built, technologically advanced lab spaces, cancer units, education zones and a public laboratory, designed to engage the community and showcase current and emerging technologies.
A collaboration between Children’s Cancer Institute; Kids Cancer Centre at Sydney Children’s Hospital, Randwick; the University of NSW; and Minderoo Foundation, this state-of-the-art facility will house more than 900 researchers, scientists and clinicians, working side-by-side with the single goal of improving care and outcomes for children with cancer.
Spanning 20,000 square metres across the new Randwick Health & Innovation Precinct and adjacent UNSW Health Translational Hub, the centre will co-locate paediatric healthcare, education and research to accelerate learning and discoveries. Findings from the innovation bench will flow to bedside care, supporting the complex needs of children and young adults with cancer.
Minderoo Children’s Comprehensive Cancer Centre will adopt a fully integrated approach to transforming the model of care for diagnosing and treating paediatric cancer. This will allow both research and clinical care teams to be involved in every step of a child’s cancer journey, from discovery to diagnosis, right through treatment and to long-term follow-up.
Minderoo Children’s Comprehensive Cancer Centre is set to have national and global impact through the sharing of expertise, data and research outcomes, ensuring children worldwide benefit from its discoveries.
When it opens in 2025, Minderoo Children’s Comprehensive Cancer Centre will be home to the world-leading Zero Childhood Cancer Precision Medicine Program (ZERO), also supported by Minderoo Foundation.
ZERO embraces research-driven clinical care, providing in-depth genomic analysis for each child, to achieve better outcomes for children with cancer, now and into the future. By the end of 2023, ZERO will be available to all children and young adults diagnosed with cancer in Australia.
ZERO is a truly collaborative effort, involving all nine children’s hospitals treating cancer patients, together with 22 national and international research partners.
The collaboration between Minderoo Children’s Comprehensive Cancer Centre and ZERO will accelerate advances in research and clinical care, generate collaborative data for sharing and lead to new, ground-breaking targeted treatments.